CompletedNCT01873911

Neurobehavioral Phenotypes in MPS III

Studying Sanfilippo syndrome type A

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Minnesota
Principal Investigator: Elsa G Shapiro, PhD, PhD
University of Minnesota
Enrollment: 30 enrolled
Eligibility: 2-12 years · All sexes
Timeline: 2010 – 2014

Study locations (1)

University of Minnesota, Minneapolis, Minnesota, United States

Collaborators

Rare Diseases Clinical Research Network · National Center for Advancing Translational Sciences (NCATS) · National Institute of Neurological Disorders and Stroke (NINDS) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · National MPS Society · Shire Human Genetic Therapies, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01873911 on ClinicalTrials.gov

Other trials for Sanfilippo syndrome type A

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE1NCT06567769
Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)
GC Biopharma Corp

See all trials for Sanfilippo syndrome type A →

← Back to all trials